Targeted evolution to increase the oncolytic potential of RNA viruses
Characterisation of the antigenic recognition of a new chimeric antibody for use in cancer immunotherapy
Search for molecular interactors of bovine leukaemia virus tax and protease proteins as potential drug targets
